Jenny Chen, Ph.D. - McDermott Will & Emery


Jenny Chen, Ph.D. counsels both US and international clients in a wide-array of patent-related matters in the life science space, including prosecution, opinion, due diligence, licensing and post-grant proceedings. Her practice focuses on matters including antibodies, cell therapies, gene therapies, small molecule therapeutics, diagnosis and pharmaceutical formulations.

She is particularly experienced in strategic counseling on life cycle management of both biological and small molecule products.

Show More


  • Built world-wide patent portfolios covering an antibody product, which obtained marketing approval in various countries*
  • Conducted clearance analysis in connection with clients’ generic and biosimilar drug development*
  • Conducted due diligence studies on patent landscape and market exclusivity in connection with biotech transaction*

Show More


  • Legal 500 US, 2021
  • The Best Lawyers in America, Patent Law, 2022-2023
  • Massachusetts Super Lawyers Rising Star, Intellectual Property
  • IAM Patent 1000, Recommended for Prosecution, 2021-2022


  • American Bar Association
  • American Intellectual Property Law Association
  • Boston Patent Law Association


Northeastern University School of Law, Boston, J.D., 2006
Baylor College of Medicine, Ph.D., Pharmacology, 2000
Fudan University, B.S., Biochemistry, 1992

United States Trademark & Patent Office